Osmotic gradient between intravascular space and brain parenchyma (null)

The “osmotic gradient between intravascular space and brain parenchyma” is the difference in osmotic pressure across the blood-brain barrier, primarily determined by solute concentrations in blood vs. brain tissue. It regulates the direction and magnitude of water movement between the vasculature and the brain, and is a key determinant in the development or resolution of cerebral edema. Modulation of this gradient (usually pharmacologically, e.g., with mannitol) is used clinically to decrease intracranial pressure or facilitate drug delivery by temporarily disrupting the BBB. However, the gradient itself is not a discrete, targetable biological molecule or drug target, but a biophysical property resulting from the integrated action of solutes, vessels, and the BBB’s structural components[2][4][1][3][5][9].

Other names

Osmotic pressure gradient across blood-brain barrierBrain-blood osmotic gradientBlood-brain osmotic gradient

Drugs (e.g., mannitol) increase plasma osmolality, creating a transient osmotic gradient that pulls water from brain parenchyma into intravascular space, or transiently opens the BBB to enhance drug delivery